CartiHeal For Profit
Latest News All Posts Agili-C™ IDE Clinical StudyOur pivotal study included US and OUS centers to evaluate the safety and effectiveness of Agili-C compared to the current surgical standard of care in traumatic and arthritic lesions. The study is prospective, multicenter, open-label, randomized and controlled. The results
Founded Date:
2009-01-01
Headquarters:
Kfar Saba, HaMerkaz, Israel
Technology:
Biomarker panels
Employee Number:
501-1000
Industry:
Clinical Data Management
Estimated Revenue:
$180